Skip to main content
Home
User account menu
  • New account request
  • Log in

Baseline Monograph - African American Women: Medications - Current Prescriptions

Back to Baseline Monograph

 


Age In Three Categories
65-6970-7980+
NUMBER OF MEDICATIONSNONE 23 12.0% 42 13.7% 13 16.3%
ONE 33 17.3% 34 11.1% 8 10.0%
TWO 37 19.4% 62 20.3% 17 21.3%
THREE 32 16.8% 51 16.7% 14 17.5%
FOUR 31 16.2% 39 12.7% 7 8.8%
FIVE 16 8.4% 31 10.1% 9 11.3%
SIX TO NINE 18 9.4% 41 13.4% 12 15.0%
TEN OR MORE 1 .5% 6 2.0%

ANY CALCIUM CHANNEL BLOCKERSNO 145 75.9% 220 71.9% 63 78.8%
YES 46 24.1% 86 28.1% 17 21.3%
DIGITALISNO 188 98.4% 285 93.1% 68 85.0%
YES 3 1.6% 21 6.9% 12 15.0%
NITRATESNO 173 90.6% 268 87.6% 67 83.8%
YES 18 9.4% 38 12.4% 13 16.3%
CLASS 1A ANTI-ARRHYTHMICSNO 190 99.5% 298 97.4% 79 98.8%
YES 1 .5% 8 2.6% 1 1.3%
ANY LIPID LOWERING MEDICATIONNO 174 91.1% 277 90.5% 80 100.0%
YES 17 8.9% 29 9.5%

ORAL HYPOGLYCEMICSNO 173 90.6% 263 85.9% 74 92.5%
YES 18 9.4% 43 14.1% 6 7.5%
INSULINNO 174 91.1% 293 95.8% 76 95.0%
YES 17 8.9% 13 4.2% 4 5.0%
ESTROGENSNO 170 89.0% 285 93.1% 79 98.8%
YES 21 11.0% 21 6.9% 1 1.3%
PHOSPHODIESTERASE INHIBITORSNO 182 95.3% 296 96.7% 78 97.5%
YES 9 4.7% 10 3.3% 2 2.5%
SYMPATHOMIMETIC (ADRENERGIC) AGENTSNO 184 96.3% 293 95.8% 79 98.8%
YES 7 3.7% 13 4.2% 1 1.3%
TRI- / TETRA- CYCLIC ANTI-DEPRESSANTSNO 186 97.4% 297 97.1% 78 97.5%
YES 5 2.6% 9 2.9% 2 2.5%
NON-TRICYCLIC ANTIDEPRESSANTSNO 189 99.0% 298 97.4% 80 100.0%
YES 2 1.0% 8 2.6%

COMB. DRUGS -- TRICYCLICS & ANTI-PSYCHOTICSNO 191 100.0% 306 100.0% 80 100.0%
ANTI-PSYCHOTICSNO 190 99.5% 305 99.7% 79 98.8%
YES 1 .5% 1 .3% 1 1.3%
ASPIRIN (ANTI-INFLAM AGENTS)NO 180 94.2% 293 95.8% 77 96.3%
YES 11 5.8% 13 4.2% 3 3.8%
NON-STEROIDAL ANTI-INFLAM (NO ASPIRIN)NO 157 82.2% 248 81.0% 69 86.3%
YES 34 17.8% 58 19.0% 11 13.8%
BENZODIAZEPINESNO 178 93.2% 285 93.1% 75 93.8%
YES 13 6.8% 21 6.9% 5 6.3%
ANY ACE INHIBITORNO 167 87.4% 259 84.1% 66 82.5%
YES 24 12.6% 49 15.9% 14 17.5%
ANY DIURETICNO 121 63.4% 161 52.3% 45 56.3%
YES 70 36.6% 147 47.7% 35 43.8%
ANY HYPERTENSION MEDNO 67 35.1% 95 30.8% 25 31.3%
YES 124 64.9% 213 69.2% 55 68.8%
ANY BETA BLOCKERNO 162 84.8% 283 91.9% 75 93.8%
YES 29 15.2% 25 8.1% 5 6.3%
ANY VASO DILATORNO 174 91.1% 273 88.6% 66 82.5%
YES 17 8.9% 35 11.4% 14 17.5%

Main navigation

  • Home
  • About CHS
    • CHS Overview
    • Design, Rationale and Objectives
    • Principal Investigators and Study Sites
    • CHS Listing at NHLBI
  • Researchers
    • Welcome New Investigators
    • Working Groups
    • Data & Specimens
    • Data Documentation
    • Ancillary Studies
    • Publications Policy
    • Presentations Policy
    • Funding CHS
    • Forms & Agreements
  • Participants
    • Newsletters
    • CHS Healthy Life Calculator
  • Contact Us
  • FAQ
  • Log in

Search